C83.7A

Clinical Causes: Infection with the Epstein-Barr virus (EBV), which is associated with many cases, especially in endemic regions. Genetic factors, including specific chromosomal translocations involving the MYC gene. Immunodeficiency conditions, such as HIV/AIDS or immunosuppressive therapy following organ transplant. Geographic regions where the endemic form is common, mainly parts of Africa. Exposure to certain chemicals or environmental toxins, though this is less well established.

Key Symptoms: Rapidly enlarging lymph nodes, often in the neck or jaw. Abdominal pain and swelling, which may be due to tumors in the stomach, intestines, or other abdominal organs. Facial swelling or tumors, especially in endemic areas. Night sweats, fever, or unexplained weight loss. Fatigue or weakness. Digestive issues such as nausea or vomiting if the gastrointestinal tract is involved. In cases involving the central nervous system, symptoms might include headaches, seizures, or neurological deficits.

Diagnosis Path: Physical examination to identify swollen lymph nodes or masses. Blood tests to check for abnormal cells and overall health status. Imaging tests such as CT scans, MRI, or PET scans to locate and assess tumors. Lymph node biopsy, which involves removing a tissue sample for microscopic examination to confirm cancer type. Bone marrow biopsy in some cases to determine if the disease has spread. Molecular and genetic tests to identify characteristic chromosomal translocations involving the MYC gene, confirming the diagnosis.

Treatment Protocols: Chemotherapy regimens specifically designed for high-grade lymphomas to eliminate cancer cells. Targeted therapies that attack specific molecules involved in cancer growth. Immunotherapy approaches to boost the body's ability to fight cancer. Radiation therapy, used in some cases to target localized areas of disease. Supportive care to manage side effects and maintain overall health during treatment. Follow-up care involving regular medical check-ups, imaging, and laboratory tests to monitor for potential relapse.